|
GS165707: MP:0000428 abnormal craniofacial morphology
|
|
GS185131: GO:0044699 single-organism process
|
|
GS168997: MP:0009640 abnormal renal tubule epithelium morphology
|
|
GS184027: GO:0006066 alcohol metabolic process
|
|
GS165342: MP:0001890 anencephaly
|
|
GS205884: GO:0016311 dephosphorylation
|
|
GS171644: HP:0011842 Abnormality of skeletal morphology
|
|
GS174960: HP:0011932 Abnormality of the superior cerebellar peduncle
|
|
GS188385: GO:0034593 phosphatidylinositol bisphosphate phosphatase activity
|
|
GS175130: HP:0000750 Delayed speech and language development
|
|
GS169830: MP:0005384 cellular phenotype
|
|
GS190997: GO:0044281 small molecule metabolic process
|
|
GS172261: HP:0000357 Abnormal location of ears
|
|
GS172633: HP:0002871 Central apnea
|
|
GS174134: HP:0002012 Abnormality of the abdominal organs
|
|
GS125369: Lamivudine interacting genes (MeSH:D019259) in CTD
|
|
GS165382: MP:0001260 increased body weight
|
|
GS166394: MP:0003728 abnormal retinal photoreceptor layer morphology
|
|
GS202709: GO:0052745 inositol phosphate phosphatase activity
|
|
GS36049: Neocortex Gene expression correlates of Light- Dark Box Total seconds spent in light compartment in Females & Males BXD
|
|
GS167046: MP:0003881 abnormal nephron morphology
|
|
GS172643: HP:0002365 Hypoplasia of the brainstem
|
|
GS166406: MP:0002110 abnormal digit morphology
|
|
GS175439: HP:0009136 Duplication involving bones of the feet
|
|
GS176151: HP:0000256 Macrocephaly
|
|
GS176385: HP:0001249 Intellectual disability
|
|
GS172701: HP:0002650 Scoliosis
|
|
GS170969: HP:0000157 Abnormality of the tongue
|
|
GS172363: HP:0004324 Increased body weight
|
|
GS35675: Whole Brain Gene expression correlates of Morphine photocell counts minutes 75-90 in Males BXD
|
|
GS170021: MP:0011087 complete neonatal lethality
|
|
GS176107: HP:0000929 Abnormality of the skull
|
|
GS176220: HP:0011620 Abnormality of abdominal situs
|
|
GS173995: HP:0000508 Ptosis
|
|
GS206874: GO:0006650 glycerophospholipid metabolic process
|
|
GS36697: Whole Brain Gene expression correlates of Morphine Vertical Activity 30-45 min in Females BXD
|
|
GS35705: Whole Brain Gene expression correlates of Morphine distance (cm) travelled minutes 105-120 in Males BXD
|
|
GS175332: HP:0000032 Abnormality of male external genitalia
|
|
GS166938: MP:0002828 abnormal renal glomerular capsule morphology
|
|
GS209602: GO:0051960 regulation of nervous system development
|
|
GS172825: HP:0001829 Polydactyly (feet)
|
|
GS136612: colon tumor susceptibility 2 (Scc2, Published QTL Chr 2)
|
|
GS35700: Whole Brain Gene expression correlates of Morphine distance (cm) travelled minutes 105-120 in Females BXD
|
|
GS172054: HP:0001507 Growth abnormality
|
|
GS177404: GO:0005737 cytoplasm
|
|
GS177265: GO:0048731 system development
|
|
GS201251: GO:0044424 intracellular part
|
|
GS36702: Whole Brain Gene expression correlates of Morphine Vertical Activity 30-45 min in Males BXD
|
|
GS178359: GO:0071840 cellular component organization or biogenesis
|
|
GS181893: GO:0048522 positive regulation of cellular process
|
|
GS188142: GO:0048856 anatomical structure development
|
|
GS176263: HP:0100259 Postaxial polydactyly
|
|
GS84122: ethanol conditioned taste aversion (Published QTL, Chr 2)
|
|
GS165194: MP:0001533 abnormal skeleton physiology
|
|
GS165228: MP:0005382 craniofacial phenotype
|
|
GS170425: MP:0004508 abnormal pectoral girdle bone morphology
|
|
GS84123: METH responses for climbing (Published QTL, Chr 2)
|
|
GS164333: MP:0000516 abnormal renal/urinary system morphology
|
|
GS172063: HP:0000107 Renal cysts
|
|
GS172570: HP:0000341 Narrow forehead
|
|
GS176241: HP:0010935 Abnormality of the upper urinary tract
|
|
GS196988: GO:0045595 regulation of cell differentiation
|
|
GS195576: GO:0016791 phosphatase activity
|
|
GS178357: GO:0071842 cellular component organization at cellular level
|
|
GS36607: Whole Brain Gene expression correlates of Morphine vertical activity counts minutes 105-120 in Females BXD
|
|
GS192944: GO:0050767 regulation of neurogenesis
|
|
GS176242: HP:0004207 Abnormality of the 5th finger
|
|
GS188446: GO:0000139 Golgi membrane
|
|
GS198912: GO:0046838 phosphorylated carbohydrate dephosphorylation
|
|
GS205500: GO:0071944 cell periphery
|
|
GS174378: HP:0000518 Cataract
|
|
GS169962: MP:0001286 abnormal eye development
|
|
GS174187: HP:0001595 Abnormality of the hair
|
|
GS171436: HP:0000077 Abnormality of the kidney
|
|
GS197927: GO:0010975 regulation of neuron projection development
|
|
GS200827: GO:0006066 alcohol metabolic process
|
|
GS171277: HP:0100547 Abnormality of the forebrain
|
|
GS181136: GO:0010975 regulation of neuron projection development
|
|
GS192074: GO:1901575 organic substance catabolic process
|
|
GS178254: GO:0031344 regulation of cell projection organization
|
|
GS163824: MP:0001259 abnormal body weight
|
|
GS172511: HP:0002335 Agenesis of cerebellar vermis
|
|
GS173146: HP:0011282 Abnormality of the hindbrain
|
|
GS179236: GO:0048699 generation of neurons
|
|
GS182763: GO:0043647 inositol phosphate metabolic process
|
|
GS185585: GO:0044710 single-organism metabolic process
|
|
GS198911: GO:0046839 phospholipid dephosphorylation
|
|
GS173242: HP:0001337 Tremor
|
|
GS176837: HP:0002790 Neonatal breathing dysregulation
|
|
GS163432: MP:0006069 abnormal retinal neuronal layer morphology
|
|
GS172095: HP:0000588 Optic nerve coloboma
|
|
GS35680: Whole Brain Gene expression correlates of Morphine distance (cm) travelled minutes 90-105 in Females & Males BXD
|
|
GS172134: HP:0000639 Nystagmus
|
|
GS136522: platelet quantitative locus 1 (Pltq1, Published QTL Chr 2)
|
|
GS33944: Whole Brain Gene expression correlates of Morphine distance (cm) travelled minutes 120-135 in Females & Males BXD
|
|
GS135533: cobblestone area-forming cell number QTL 1 (Cafcnq1, Published QTL Chr 2)
|
|
GS168502: MP:0002058 neonatal lethality
|
|
GS175263: HP:0001161 Polydactyly (hands)
|
|
GS175601: HP:0002086 Abnormality of the respiratory system
|
|
GS176437: HP:0002334 Abnormality of the cerebellar vermis
|
|
GS170933: HP:0001288 Gait disturbance
|
|
GS171999: HP:0001760 Abnormality of the foot
|
|
GS178284: GO:0031090 organelle membrane
|
|
GS172842: HP:0000480 Retinal coloboma
|
|
GS196667: GO:0008610 lipid biosynthetic process
|
|
GS176203: HP:0000478 Abnormality of the eye
|
|
GS194455: GO:0051239 regulation of multicellular organismal process
|
|
GS172185: HP:0002977 Aplasia/Hypoplasia involving the central nervous system
|
|
GS202602: GO:0006644 phospholipid metabolic process
|
|
GS175110: HP:0000570 Abnormality of saccadic eye movements
|
|
GS171787: HP:0001395 Hepatic fibrosis
|
|
GS176589: HP:0001273 Abnormality of the corpus callosum
|
|
GS181135: GO:0010976 positive regulation of neuron projection development
|
|
GS167615: MP:0003935 abnormal craniofacial development
|
|
GS169057: MP:0000914 exencephaly
|
|
GS136471: periosteal circumference and femur length 1 (Pcfm1, Published QTL Chr 2)
|
|
GS179362: GO:0005929 cilium
|
|
GS196284: GO:0012505 endomembrane system
|
|
GS184537: GO:0071545 inositol phosphate catabolic process
|
|
GS172360: HP:0004323 Abnormality of body weight
|
|
GS135816: ethanol induced ataxia 3 (Etax3, Published QTL Chr 2)
|
|
GS174701: HP:0000556 Retinal dystrophy
|
|
GS197892: GO:0043228 non-membrane-bounded organelle
|
|
GS166409: MP:0002114 abnormal axial skeleton morphology
|
|
GS192299: GO:0006793 phosphorus metabolic process
|
|
GS208716: GO:2000026 regulation of multicellular organismal development
|
|
GS196808: GO:0032501 multicellular organismal process
|
|
GS178401: GO:0019637 organophosphate metabolic process
|
|
GS186744: GO:0043226 organelle
|
|
GS188750: GO:0044431 Golgi apparatus part
|
|
GS171047: HP:0008736 Hypoplasia of penis
|
|
GS175880: HP:0007370 Aplasia/Hypoplasia of the corpus callosum
|
|
GS167521: MP:0005306 abnormal phalanx morphology
|
|
GS182835: GO:0005622 intracellular
|
|
GS205439: GO:0031175 neuron projection development
|
|
GS202415: GO:0044710 single-organism metabolic process
|
|
GS213074: Genes with suggestive difference in (B6PF1) vs (PB6F1 + B6 + PWD) comparison
|
|
GS165346: MP:0009883 palatal shelf hypoplasia
|
|
GS169832: MP:0005381 digestive/alimentary phenotype
|
|
GS176844: HP:0000429 Abnormality of the nasal alae
|
|
GS207903: GO:0044281 small molecule metabolic process
|
|
GS171253: HP:0002817 Abnormality of the upper limb
|
|
GS194133: GO:0005737 cytoplasm
|
|
GS176231: HP:0010938 Abnormality of the external nose
|
|
GS205302: GO:0000139 Golgi membrane
|
|
GS170680: MP:0003744 abnormal orofacial morphology
|
|
GS174300: HP:0000718 Aggressive behavior
|
|
GS201341: GO:0071545 inositol phosphate catabolic process
|
|
GS34243: Neocortex Gene expression correlates of Light-Dark Box Percentage time in light in Males BXD
|
|
GS175676: HP:0007362 Aplasia/Hypoplasia of the brainstem
|
|
GS35525: Whole Brain Gene expression correlates of Morphine photocell counts minutes 90-105 in Males BXD
|
|
GS174217: HP:0005105 Abnormal nasal morphology
|
|
GS136890: voluntary alcohol consumption QTL 4 (Vacq4, Published QTL Chr 2)
|
|
GS175525: HP:0000004 Onset and clinical course
|
|
GS191129: GO:0016787 hydrolase activity
|
|
GS172484: HP:0009997 Duplication of phalanx of hand
|
|
GS192628: GO:0048666 neuron development
|
|
GS179519: GO:0012505 endomembrane system
|
|
GS166118: MP:0002109 abnormal limb morphology
|
|
GS194307: GO:0016043 cellular component organization
|
|
GS163803: MP:0003631 nervous system phenotype
|
|
GS171946: HP:0002269 Abnormality of neuronal migration
|
|
GS175500: HP:0000517 Abnormality of the lens
|
|
GS173079: HP:0000496 Abnormality of eye movement
|
|
GS165361: MP:0004624 abnormal thoracic cage morphology
|
|
GS189751: GO:0050794 regulation of cellular process
|
|
GS173991: HP:0000505 Visual impairment
|
|
GS209010: GO:1901575 organic substance catabolic process
|
|
GS163318: MP:0000521 abnormal kidney cortex morphology
|
|
GS128575: Ethanol induced LORR Chr# 2
|
|
GS175528: HP:0000007 Autosomal recessive inheritance
|
|
GS171815: HP:0001574 Abnormality of the integument
|
|
GS177031: HP:0011442 Abnormality of central motor function
|
|
GS185492: GO:0050789 regulation of biological process
|
|
GS172354: HP:0004328 Abnormality of the anterior segment of the eye
|
|
GS173187: HP:0007772 Impaired smooth pursuit
|
|
GS184010: GO:0030030 cell projection organization
|
|
GS36029: Neocortex Gene expression correlates of Light-Dark Box Total seconds spent in dark compartment in Males BXD
|
|
GS175526: HP:0000005 Mode of inheritance
|
|
GS172232: HP:0002195 Dysgenesis of the cerebellar vermis
|
|
GS174836: HP:0001098 Abnormality of the fundus
|
|
GS180036: GO:0032501 multicellular organismal process
|
|
GS187237: GO:0030182 neuron differentiation
|
|
GS196930: GO:0065007 biological regulation
|
|
GS192512: GO:0003824 catalytic activity
|
|
GS194970: GO:0046030 inositol trisphosphate phosphatase activity
|
|
GS169298: MP:0009655 abnormal secondary palate development
|
|
GS166294: MP:0011109 partial lethality throughout fetal growth and development
|
|
GS207616: GO:0016020 membrane
|
|
GS171647: HP:0011844 Abnormal appendicular skeleton morphology
|
|
GS36677: Whole Brain Gene expression correlates of Morphine vertical activity counts minutes 15-30 in Females & Males BXD
|
|
GS180229: GO:0005886 plasma membrane
|
|
GS198004: GO:0007399 nervous system development
|
|
GS191779: GO:2000026 regulation of multicellular organismal development
|
|
GS176170: HP:0001252 Muscular hypotonia
|
|
GS129163: proteoglycan induced spondylitis 2 (Pgis2 Published QTL Chr 2)
|
|
GS163601: MP:0002089 abnormal postnatal growth/weight/body size
|
|
GS177094: GO:0006629 lipid metabolic process
|
|
GS197244: GO:0044237 cellular metabolic process
|
|
GS171658: HP:0000612 Iris coloboma
|
|
GS196055: GO:0008654 phospholipid biosynthetic process
|
|
GS175264: HP:0001162 Postaxial polydactyly (hands)
|
|
GS179132: GO:0044255 cellular lipid metabolic process
|
|
GS185024: GO:0044463 cell projection part
|
|
GS35535: Whole Brain Gene expression correlates of Morphine photocell counts minutes 105-120 in Females BXD
|
|
GS193991: GO:0048731 system development
|
|
GS200117: GO:0051130 positive regulation of cellular component organization
|
|
GS175631: HP:0100951 Enlarged fossa interpeduncularis
|
|
GS190065: GO:0046855 inositol phosphate dephosphorylation
|
|
GS135721: variability in response to cholestrol enriched atherogenic diet (Diet1, Published QTL Chr 2)
|
|
GS168654: MP:0000111 cleft palate
|
|
GS193068: GO:0046174 polyol catabolic process
|
|
GS173139: HP:0002418 Abnormality of the midbrain
|
|
GS135244: adiposity 10 (Adip10, Published QTL Chr 2)
|
|
GS174145: HP:0005918 Abnormality of phalanx of finger
|
|
GS196129: GO:0005929 cilium
|
|
GS165527: MP:0005378 growth/size phenotype
|
|
GS175529: HP:0000001 All
|
|
GS171655: HP:0000611 Choroid coloboma
|
|
GS169385: MP:0004320 split sternum
|
|
GS185770: GO:0006644 phospholipid metabolic process
|
|
GS36722: Whole Brain Gene expression correlates of Morphine vertical activity counts minutes 60-75 in Females & Males BXD
|
|
GS201237: GO:0046486 glycerolipid metabolic process
|
|
GS200286: GO:0060284 regulation of cell development
|
|
GS201839: GO:0044463 cell projection part
|
|
GS205609: GO:0044431 Golgi apparatus part
|
|
GS184447: GO:0044424 intracellular part
|
|
GS207862: GO:0009056 catabolic process
|
|
GS136087: lean body mass 1 (Lbm1, Published QTL Chr 2)
|
|
GS178360: GO:0071841 cellular component organization or biogenesis at cellular level
|
|
GS176660: HP:0000050 Hypoplastic genitalia
|
|
GS186740: GO:0043229 intracellular organelle
|
|
GS198012: GO:0046434 organophosphate catabolic process
|
|
GS35685: Whole Brain Gene expression correlates of Morphine distance (cm) travelled minutes 90-105 in Females BXD
|
|
GS175191: HP:0002060 Abnormality of the cerebrum
|
|
GS195036: GO:0031090 organelle membrane
|
|
GS172288: HP:0000358 Posteriorly rotated ears
|
|
GS167286: MP:0008528 polycystic kidney
|
|
GS172670: HP:0002363 Abnormality of the brainstem
|
|
GS197926: GO:0010976 positive regulation of neuron projection development
|
|
GS210010: GO:0046174 polyol catabolic process
|
|
GS197087: GO:0016310 phosphorylation
|
|
GS174712: HP:0002553 Highly arched eyebrow
|
|
GS185584: GO:0044712 single-organism catabolic process
|
|
GS176568: HP:0000486 Strabismus
|
|
GS171448: HP:0000606 Abnormality of the periorbital region
|
|
GS192328: GO:0004439 phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity
|
|
GS202025: GO:0031346 positive regulation of cell projection organization
|
|
GS208012: GO:0044464 cell part
|
|
GS210212: GO:0005575 cellular_component
|
|
GS173311: HP:0010651 Abnormality of the meninges
|
|
GS167974: MP:0009653 abnormal palate development
|
|
GS84124: ethanol consumption (Published QTL, Chr 2)
|
|
GS176202: HP:0000479 Abnormality of the retina
|
|
GS188399: GO:0044238 primary metabolic process
|
|
GS173020: HP:0000818 Abnormality of the endocrine system
|
|
GS206623: GO:0050794 regulation of cellular process
|
|
GS36712: Whole Brain Gene expression correlates of Morphine vertical activity counts minutes 45-60 in Females BXD
|
|
GS172219: HP:0010301 Spinal dysraphism
|
|
GS195616: GO:0032580 Golgi cisterna membrane
|
|
GS136074: insulin QTL 7 (Insq7, Published QTL Chr 2)
|
|
GS202414: GO:0044712 single-organism catabolic process
|
|
GS163832: MP:0011065 abnormal kidney epithelial cell primary cilium morphology
|
|
GS195113: GO:0071841 cellular component organization or biogenesis at cellular level
|
|
GS164261: MP:0002081 perinatal lethality
|
|
GS176835: HP:0000426 Prominent nasal bridge
|
|
GS186214: GO:0048518 positive regulation of biological process
|
|
GS187576: GO:0051128 regulation of cellular component organization
|
|
GS164887: MP:0003073 abnormal metacarpal bone morphology
|
|
GS205144: GO:0048468 cell development
|
|
GS174379: HP:0002084 Encephalocele
|
|
GS33992: Whole Brain Gene expression correlates of Morphine distance (cm) travelled minutes 75-90 in Females & Males BXD
|
|
GS176101: HP:0000924 Abnormality of the skeletal system
|
|
GS172033: HP:0000369 Low-set ears
|
|
GS35665: Whole Brain Gene expression correlates of Morphine photocell counts minutes 75-90 in Females & Males BXD
|
|
GS176801: HP:0001263 Global developmental delay
|
|
GS171773: HP:0000532 Chorioretinal abnormality
|
|
GS172195: HP:0000504 Abnormality of vision
|
|
GS201235: GO:0046488 phosphatidylinositol metabolic process
|
|
GS171656: HP:0000610 Abnormality of the choroid
|
|
GS174500: HP:0000707 Abnormality of the nervous system
|
|
GS168149: MP:0005508 abnormal skeleton morphology
|
|
GS167020: MP:0003956 abnormal body size
|
|
GS189020: GO:0016311 dephosphorylation
|
|
GS169887: MP:0008272 abnormal endochondral bone ossification
|
|
GS170380: MP:0003755 abnormal palate morphology
|
|
GS176478: HP:0002119 Ventriculomegaly
|
|
GS35515: Whole Brain Gene expression correlates of Morphine photocell counts minutes 90-105 in Females & Males BXD
|
|
GS164164: MP:0009887 abnormal palatal shelf fusion at midline
|
|
GS176834: HP:0002793 Abnormal respiratory patterns
|
|
GS182834: GO:0005623 cell
|
|
GS177051: HP:0001155 Abnormality of the hand
|
|
GS36587: Whole Brain Gene expression correlates of Morphine vertical activity counts minutes 90-105 in Females & Males BXD
|
|
GS173083: HP:0000492 Abnormality of the eyelid
|
|
GS197043: GO:0044282 small molecule catabolic process
|
|
GS196002: GO:0048699 generation of neurons
|
|
GS194400: GO:0006661 phosphatidylinositol biosynthetic process
|
|
GS198370: GO:0042578 phosphoric ester hydrolase activity
|
|
GS169530: MP:0005390 skeleton phenotype
|
|
GS173140: HP:0011534 Abnormal spatial orientation of the cardiac segments
|
|
GS175335: HP:0000036 Abnormality of the penis
|
|
GS164411: MP:0000562 polydactyly
|
|
GS173617: HP:0011220 Prominent forehead
|
|
GS174914: HP:0003011 Abnormality of the musculature
|
|
GS182474: GO:0043232 intracellular non-membrane-bounded organelle
|
|
GS199635: GO:0005622 intracellular
|
|
GS163319: MP:0000522 kidney cortex cysts
|
|
GS171055: HP:0002342 Intellectual disability, moderate
|
|
GS121976: Zidovudine interacting genes (MeSH:D015215) in CTD
|
|
GS168012: MP:0010832 lethality during fetal growth through weaning
|
|
GS207365: GO:0005829 cytosol
|
|
GS176038: HP:0002795 Functional respiratory abnormality
|
|
GS196943: GO:0008152 metabolic process
|
|
GS125187: Sulindac interacting genes (MeSH:D013467) in CTD
|
|
GS175635: HP:0002251 Aganglionic megacolon
|
|
GS204325: GO:0019751 polyol metabolic process
|
|
GS180305: GO:0016310 phosphorylation
|
|
GS202625: GO:0045017 glycerolipid biosynthetic process
|
|
GS121437: Fluorouracil interacting genes (MeSH:D005472) in CTD
|
|
GS171543: HP:0000276 Long face
|
|
GS136554: pentylenetetrazol induced seizure susceptibility 1b (Ptz1b, Published QTL Chr 2)
|
|
GS205241: GO:0034593 phosphatidylinositol bisphosphate phosphatase activity
|
|
GS173206: HP:0003241 Genital hypoplasia
|
|
GS170285: MP:0004967 abnormal kidney epithelium morphology
|
|
GS174075: HP:0009121 Abnormal axial skeleton morphology
|
|
GS196941: GO:0008150 biological_process
|
|
GS208043: GO:0016788 hydrolase activity, acting on ester bonds
|
|
GS199634: GO:0005623 cell
|
|
GS36687: Whole Brain Gene expression correlates of Morphine vertical activity counts minutes 15-30 in Males BXD
|
|
GS165567: MP:0008271 abnormal bone ossification
|
|
GS164136: MP:0000001 mammalian phenotype
|
|
GS190893: GO:0030154 cell differentiation
|
|
GS197009: GO:0005886 plasma membrane
|
|
GS36622: Whole Brain Gene expression correlates of Morphine vertical activity counts minutes 120-135 in Females BXD
|
|
GS175455: HP:0002508 Malformation of brainstem structures
|
|
GS201256: GO:0044422 organelle part
|
|
GS35550: Whole Brain Gene expression correlates of Morphine photocell counts minutes 120-135 in Females BXD
|
|
GS175814: HP:0011024 Abnormality of the gastrointestinal tract
|
|
GS173743: HP:0001999 Abnormal facial shape
|
|
GS176613: HP:0000271 Abnormality of the face
|
|
GS175928: HP:0000240 Abnormality of skull size
|
|
GS206569: GO:0045664 regulation of neuron differentiation
|
|
GS135222: aromatase activity QTL 3 (Aaiq3, Published QTL Chr 2)
|
|
GS173147: HP:0011283 Abnormality of the metencephalon
|
|
GS209411: GO:0048869 cellular developmental process
|
|
GS178220: GO:0046030 inositol trisphosphate phosphatase activity
|
|
GS36692: Whole Brain Gene expression correlates of Morphine Vertical Activity 30-45 min in Females & Males BXD
|
|
GS187160: GO:0044707 single-multicellular organism process
|
|
GS172992: HP:0001320 Cerebellar vermis hypoplasia
|
|
GS173217: HP:0005957 Breathing dysregulation
|
|
GS175016: HP:0001626 Abnormality of the cardiovascular system
|
|
GS175670: HP:0007364 Aplasia/Hypoplasia of the cerebrum
|
|
GS190682: GO:0007275 multicellular organismal development
|
|
GS175990: HP:0000463 Anteverted nares
|
|
GS191954: GO:0005856 cytoskeleton
|
|
GS136515: plasma plant sterol 2a (Plast2a, Published QTL Chr 2)
|
|
GS195110: GO:0071842 cellular component organization at cellular level
|
|
GS193059: GO:0044446 intracellular organelle part
|
|
GS205244: GO:0034595 phosphatidylinositol phosphate 5-phosphatase activity
|
|
GS176393: HP:0011933 Elongated superior cerebellar peduncle
|
|
GS176172: HP:0001251 Ataxia
|
|
GS209564: GO:0043231 intracellular membrane-bounded organelle
|
|
GS182118: GO:0046839 phospholipid dephosphorylation
|
|
GS170961: HP:0000158 Macroglossia
|
|
GS188388: GO:0034595 phosphatidylinositol phosphate 5-phosphatase activity
|
|
GS171274: HP:0100543 Cognitive impairment
|
|
GS180208: GO:0045595 regulation of cell differentiation
|
|
GS200626: GO:0044262 cellular carbohydrate metabolic process
|
|
GS36727: Whole Brain Gene expression correlates of Morphine vertical activity counts minutes 60-75 in Females BXD
|
|
GS204095: GO:0030182 neuron differentiation
|
|
GS188826: GO:0022008 neurogenesis
|
|
GS175981: HP:0000163 Abnormality of the oral cavity
|
|
GS35545: Whole Brain Gene expression correlates of Morphine photocell counts minutes 120-135 in Females & Males BXD
|
|
GS165160: MP:0006207 embryonic lethality during organogenesis
|
|
GS170534: MP:0011066 abnormal renal tubule epithelial cell primary cilium morphology
|
|
GS136228: mandible length 2 (Manln2, Published QTL Chr 2)
|
|
GS199272: GO:0043232 intracellular non-membrane-bounded organelle
|
|
GS165427: MP:0000432 abnormal head morphology
|
|
GS173262: HP:0000864 Abnormality of the hypothalamus-pituitary axis
|
|
GS206950: GO:0046856 phosphatidylinositol dephosphorylation
|
|
GS176100: HP:0000925 Abnormality of the vertebral column
|
|
GS206952: GO:0046854 phosphatidylinositol phosphorylation
|
|
GS171848: HP:0000598 Abnormality of the ear
|
|
GS185207: GO:0031346 positive regulation of cell projection organization
|
|
GS175015: HP:0001627 Abnormality of the heart
|
|
GS175096: HP:0000286 Epicanthus
|
|
GS204021: GO:0044707 single-multicellular organism process
|
|
GS172139: HP:0010993 Abnormality of the cerebral subcortex
|
|
GS170884: HP:0006919 Abnormal aggressive, impulsive or violent behavior
|
|
GS36019: Neocortex Gene expression correlates of Light-Dark Box Total seconds spent in dark compartment in Females & Males BXD
|
|
GS36742: Whole Brain Gene expression correlates of Morphine vertical activity counts minutes 75-90 in Females BXD
|
|
GS176186: HP:0000079 Abnormality of the urinary system
|
|
GS167210: MP:0009744 postaxial polydactyly
|
|
GS36059: Neocortex Gene expression correlates of Light- Dark Box Total seconds spent in light compartment in Males BXD
|
|
GS172620: HP:0000657 Oculomotor apraxia
|
|
GS173031: HP:0004362 Abnormality of the enteric ganglia
|
|
GS163971: MP:0002092 abnormal eye morphology
|
|
GS127240: Acetaminophen interacting genes (MeSH:D000082) in CTD
|
|
GS201074: GO:0005795 Golgi stack
|
|
GS171621: HP:0100851 Abnormal emotion/affect behavior
|
|
GS180152: GO:0065007 biological regulation
|
|
GS165536: MP:0005371 limbs/digits/tail phenotype
|
|
GS171661: HP:0000617 Abnormality of ocular smooth pursuit
|
|
GS171093: HP:0007271 Occipital myelomeningocele
|
|
GS207989: GO:0035085 cilium axoneme
|
|
GS171937: HP:0004346 Increased respiratory rate or depth of breathing
|
|
GS135851: fecundity QTL 1 (Fecq1, Published QTL Chr 2)
|
|
GS171789: HP:0001392 Abnormality of the liver
|
|
GS171403: HP:0001956 Truncal obesity
|
|
GS172749: HP:0002436 Occipital meningocele
|
|
GS209568: GO:0048666 neuron development
|
|
GS36717: Whole Brain Gene expression correlates of Morphine vertical activity counts minutes 45-60 in Males BXD
|
|
GS201075: GO:0005794 Golgi apparatus
|
|
GS189692: GO:0045664 regulation of neuron differentiation
|
|
GS173165: HP:0002435 Meningocele
|
|
GS173024: HP:0000811 Abnormal external genitalia
|
|
GS196806: GO:0032502 developmental process
|
|
GS206618: GO:0050793 regulation of developmental process
|
|
GS170965: HP:0000153 Abnormality of the mouth
|
|
GS171465: HP:0004275 Duplication of hand bones
|
|
GS181215: GO:0007399 nervous system development
|
|
GS209547: GO:0031985 Golgi cisterna
|
|
GS203594: GO:0043226 organelle
|
|
GS172667: HP:0011805 Abnormality of muscle morphology
|
|
GS199561: GO:0043647 inositol phosphate metabolic process
|
|
GS204438: GO:0051128 regulation of cellular component organization
|
|
GS174879: HP:0002104 Apnea
|
|
GS210002: GO:0044444 cytoplasmic part
|
|
GS171168: HP:0000234 Abnormality of the head
|
|
GS209009: GO:1901576 organic substance biosynthetic process
|
|
GS34352: Whole Brain Gene expression correlates of Morphine Open Field TOTAL distance (cm) travelled in Females & Males BXD
|
|
GS173102: HP:0010808 Protruding tongue
|
|
GS167217: MP:0001325 abnormal retina morphology
|
|
GS167622: MP:0002152 abnormal brain morphology
|
|
GS170104: MP:0003723 abnormal long bone morphology
|
|
GS203593: GO:0043227 membrane-bounded organelle
|
|
GS181102: GO:0043228 non-membrane-bounded organelle
|
|
GS209887: GO:0050767 regulation of neurogenesis
|
|
GS171178: HP:0000238 Hydrocephalus
|
|
GS164469: MP:0003675 kidney cysts
|
|
GS210000: GO:0044446 intracellular organelle part
|
|
GS34233: Neocortex Gene expression correlates of Light-Dark Box Percentage of distance traveled in light compartment in Males BXD
|
|
GS174131: HP:0002011 Abnormality of the central nervous system
|
|
GS202316: GO:0050789 regulation of biological process
|
|
GS194087: GO:0003674 molecular_function
|
|
GS171424: HP:0002814 Abnormality of the lower limb
|
|
GS171724: HP:0008915 Childhood-onset truncal obesity
|
|
GS174509: HP:0100716 Autoagression
|
|
GS169968: MP:0009890 cleft secondary palate
|
|
GS170351: MP:0006208 lethality throughout fetal growth and development
|
|
GS169062: MP:0000913 abnormal brain development
|
|
GS175304: HP:0000290 Abnormality of the forehead
|
|
GS177356: GO:0003674 molecular_function
|
|
GS203590: GO:0043229 intracellular organelle
|
|
GS164665: MP:0000572 abnormal autopod morphology
|
|
GS177717: GO:0051239 regulation of multicellular organismal process
|
|
GS176245: HP:0011443 Abnormality of coordination
|
|
GS172839: HP:0010674 Abnormality of the curvature of the vertebral column
|
|
GS36602: Whole Brain Gene expression correlates of Morphine vertical activity counts minutes 105-120 in Females & Males BXD
|
|
GS172725: HP:0007973 Retinal dysplasia
|
|
GS190064: GO:0046856 phosphatidylinositol dephosphorylation
|
|
GS195897: GO:0044255 cellular lipid metabolic process
|
|
GS172034: HP:0000368 Low-set, posteriorly rotated ears
|
|
GS175785: HP:0002500 Abnormality of the cerebral white matter
|
|
GS135820: ethanol consumption 1 (Etohc1, Published QTL Chr 2)
|
|
GS180264: GO:0044282 small molecule catabolic process
|
|
GS180683: GO:0046164 alcohol catabolic process
|
|
GS136889: voluntary alcohol consumption QTL 3 (Vacq3, Published QTL Chr 2)
|
|
GS209265: GO:0004439 phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity
|
|
GS170683: MP:0003743 abnormal facial morphology
|
|
GS176145: HP:0001780 Abnormality of toe
|
|
GS192471: GO:0048869 cellular developmental process
|
|
GS195002: GO:0031344 regulation of cell projection organization
|
|
GS176249: HP:0002789 Tachypnea
|
|
GS180166: GO:0008152 metabolic process
|
|
GS164446: MP:0005195 abnormal posterior eye segment morphology
|
|
GS176806: HP:0003812 Phenotypic variability
|
|
GS164929: MP:0009888 palatal shelves fail to meet at midline
|
|
GS173033: HP:0011931 Abnormality of the cerebellar peduncle
|
|
GS171832: HP:0000118 Phenotypic abnormality
|
|
GS184267: GO:0005794 Golgi apparatus
|
|
GS34361: Whole Brain Gene expression correlates of Morphine TOTAL vertical activity counts in Females & Males BXD
|
|
GS198906: GO:0046834 lipid phosphorylation
|
|
GS192255: GO:0030258 lipid modification
|
|
GS35690: Whole Brain Gene expression correlates of Morphine distance (cm) travelled minutes 90-105 in Males BXD
|
|
GS183321: GO:0051130 positive regulation of cellular component organization
|
|
GS183122: GO:0005975 carbohydrate metabolic process
|
|
GS172215: HP:0007910 Retinal dystrophy, congenital, nonprogressive
|
|
GS183826: GO:0044262 cellular carbohydrate metabolic process
|
|
GS169531: MP:0005391 vision/eye phenotype
|
|
GS175268: HP:0001167 Abnormality of finger
|
|
GS174505: HP:0000708 Behavioural/Psychiatric Abnormality
|
|
GS193812: GO:0006629 lipid metabolic process
|
|
GS165876: MP:0002135 abnormal kidney morphology
|
|
GS165809: MP:0002864 abnormal ocular fundus morphology
|
|
GS190714: GO:0016020 membrane
|
|
GS176477: HP:0002118 Abnormality of the cerebral ventricles
|
|
GS183491: GO:0060284 regulation of cell development
|
|
GS194874: GO:0052866 phosphatidylinositol phosphate phosphatase activity
|
|
GS209548: GO:0031984 organelle subcompartment
|
|
GS171139: HP:0005288 Abnormality of the nares
|
|
GS175098: HP:0000284 Abnormality of the ocular region
|
|
GS173787: HP:0002813 Abnormality of limb bone morphology
|
|
GS191552: GO:0042995 cell projection
|
|
GS176171: HP:0001250 Seizures
|
|
GS195214: GO:0009987 cellular process
|
|
GS210006: GO:0044441 cilium part
|
|
GS184452: GO:0044422 organelle part
|
|
GS172295: HP:0001513 Obesity
|
|
GS180034: GO:0032502 developmental process
|
|
GS195112: GO:0071840 cellular component organization or biogenesis
|
|
GS35695: Whole Brain Gene expression correlates of Morphine distance (cm) travelled minutes 105-120 in Females & Males BXD
|
|
GS165525: MP:0010768 mortality/aging
|
|
GS175673: HP:0100022 Abnormality of movement
|
|
GS170438: MP:0000060 delayed bone ossification
|
|
GS198636: GO:0046474 glycerophospholipid biosynthetic process
|
|
GS194250: GO:0004445 inositol-polyphosphate 5-phosphatase activity
|
|
GS164770: MP:0009250 abnormal appendicular skeleton morphology
|
|
GS172094: HP:0000589 Coloboma
|
|
GS169225: MP:0000358 abnormal cell morphology
|
|
GS173651: HP:0009142 Duplication of bones involving the upper extremities
|
|
GS191135: GO:0016788 hydrolase activity, acting on ester bonds
|
|
GS177514: GO:0004445 inositol-polyphosphate 5-phosphatase activity
|
|
GS192296: GO:0006796 phosphate-containing compound metabolic process
|
|
GS200809: GO:0030030 cell projection organization
|
|
GS175169: HP:0001317 Abnormality of the cerebellum
|
|
GS195151: GO:0019637 organophosphate metabolic process
|
|
GS174236: HP:0000534 Abnormality of the eyebrow
|
|
GS193065: GO:0044441 cilium part
|
|
GS165524: MP:0010769 abnormal survival
|
|
GS175423: HP:0010461 Abnormality of the male genitalia
|
|
GS172513: HP:0001696 Situs inversus totalis
|
|
GS208037: GO:0016787 hydrolase activity
|
|
GS175402: HP:0002876 Tachypnea, episodic
|
|
GS181578: GO:0042578 phosphoric ester hydrolase activity
|
|
GS209235: GO:0006793 phosphorus metabolic process
|
|
GS165243: MP:0010770 preweaning lethality
|
|
GS185874: GO:0052745 inositol phosphate phosphatase activity
|
|
GS174087: HP:0003363 Abdominal situs inversus
|
|
GS182114: GO:0046834 lipid phosphorylation
|
|
GS136035: induction of brown adipocytes 6 (Iba6, Published QTL Chr 2)
|
|
GS172899: HP:0011815 Cephalocele
|
|
GS172100: HP:0000587 Abnormality of the optic nerve
|
|
GS205691: GO:0022008 neurogenesis
|
|
GS182119: GO:0046838 phosphorylated carbohydrate dephosphorylation
|
|
GS210357: GO:0044249 cellular biosynthetic process
|
|
GS180452: GO:0044237 cellular metabolic process
|
|
GS174706: HP:0000553 Abnormality of the uvea
|
|
GS172353: HP:0004329 Abnormality of the posterior segment of the eye
|
|
GS169639: MP:0002703 abnormal renal tubule morphology
|
|
GS172148: HP:0010442 Polydactyly
|
|
GS203057: GO:0048518 positive regulation of biological process
|
|
GS209189: GO:0030258 lipid modification
|
|
GS165798: MP:0005367 renal/urinary system phenotype
|
|
GS174453: HP:0001438 Abnormality of the abdomen
|
|
GS180164: GO:0008150 biological_process
|
|
GS197482: GO:0046164 alcohol catabolic process
|
|
GS176333: HP:0007319 Morphological abnormality of the central nervous system
|
|
GS188287: GO:0048468 cell development
|
|
GS194460: GO:0090407 organophosphate biosynthetic process
|
|
GS172855: HP:0004307 Abnormal anatomic location of the heart
|
|
GS167505: MP:0008762 embryonic lethality
|
|
GS169552: MP:0003419 delayed endochondral bone ossification
|
|
GS170238: MP:0001293 anophthalmia
|
|
GS189746: GO:0050793 regulation of developmental process
|
|
GS205255: GO:0044238 primary metabolic process
|
|
GS171833: HP:0000119 Abnormality of the genitourinary system
|
|
GS192660: GO:0051960 regulation of nervous system development
|
|
GS206951: GO:0046855 inositol phosphate dephosphorylation
|
|
GS174833: HP:0006817 Aplasia/Hypoplasia of the cerebellar vermis
|
|
GS166923: MP:0002827 abnormal renal corpuscle morphology
|
|
GS188578: GO:0031175 neuron projection development
|
|
GS172260: HP:0000356 Abnormality of the outer ear
|
|
GS209232: GO:0006796 phosphate-containing compound metabolic process
|
|
GS173476: HP:0002311 Incoordination
|
|
GS172418: HP:0000567 Chorioretinal coloboma
|
|
GS164262: MP:0002080 prenatal lethality
|
|
GS171850: HP:0002414 Spina bifida
|
|
GS35530: Whole Brain Gene expression correlates of Morphine photocell counts minutes 105-120 in Females & Males BXD
|
|
GS199922: GO:0005975 carbohydrate metabolic process
|
|
GS208482: GO:0042995 cell projection
|
|
GS184433: GO:0046486 glycerolipid metabolic process
|
|
GS190954: GO:0009056 catabolic process
|
|
GS171258: HP:0011138 Abnormality of skin adnexa
|
|
GS209455: GO:0003824 catalytic activity
|
|
GS184218: GO:0071704 organic substance metabolic process
|
|
GS135441: bone marrow graft rejection 2 (Bmgr2, Published QTL Chr 2)
|
|
GS176836: HP:0000422 Abnormality of the nasal bridge
|
|
GS36707: Whole Brain Gene expression correlates of Morphine vertical activity counts minutes 45-60 in Females & Males BXD
|
|
GS166825: MP:0000462 abnormal digestive system morphology
|
|
GS172496: HP:0000742 Self-mutilation
|
|
GS167188: MP:0001264 increased body size
|
|
GS176826: HP:0000202 Oral cleft
|
|
GS173462: HP:0001651 Dextrocardia
|
|
GS198685: GO:0048522 positive regulation of cellular process
|
|
GS201949: GO:0044699 single-organism process
|
|
GS167526: MP:0000157 abnormal sternum morphology
|
|
GS136604: spinal bone mineral density 2 (Sbmd2, Published QTL Chr 2)
|
|
GS172666: HP:0011804 Abnormality of muscle physiology
|
|
GS188641: GO:0071944 cell periphery
|
|
GS175107: HP:0003808 Abnormal muscle tone
|
|
GS181223: GO:0046434 organophosphate catabolic process
|
|
GS164320: MP:0003861 abnormal nervous system development
|
|
GS178461: GO:0009987 cellular process
|
|
GS173946: HP:0002438 Cerebellar malformation
|
|
GS193061: GO:0044444 cytoplasmic part
|
|
GS135847: femoral cross-sectional area 5 (Fcsa5, Published QTL Chr 2)
|
|
GS192624: GO:0043231 intracellular membrane-bounded organelle
|
|
GS186743: GO:0043227 membrane-bounded organelle
|
|
GS170108: MP:0003727 abnormal retinal layer morphology
|
|
GS173113: HP:0002186 Apraxia
|
|
GS189995: GO:0006650 glycerophospholipid metabolic process
|
|
GS175837: HP:0002419 Molar tooth sign on MRI
|
|
GS174488: HP:0000525 Abnormality of the iris
|
|
GS166291: MP:0011108 partial embryonic lethality during organogenesis
|
|
GS167149: MP:0000452 abnormal mouth morphology
|
|
GS173148: HP:0003712 Muscle hypertrophy
|
|
GS136603: spinal bone mineral density 1 (Sbmd1, Published QTL Chr 2)
|
|
GS36737: Whole Brain Gene expression correlates of Morphine vertical activity counts minutes 75-90 in Females & Males BXD
|
|
GS193268: GO:0005575 cellular_component
|
|
GS173868: HP:0002143 Abnormality of the spinal cord
|
|
GS35520: Whole Brain Gene expression correlates of Morphine photocell counts minutes 90-105 in Females BXD
|
|
GS209967: GO:0005930 axoneme
|
|
GS207797: GO:0030154 cell differentiation
|
|
GS176657: HP:0000054 Micropenis
|
|
GS184431: GO:0046488 phosphatidylinositol metabolic process
|
|
GS207581: GO:0007275 multicellular organismal development
|
|
GS34916: Cerebellum Gene expression correlates of Open Field - Total distance traveled 0-5 minutes in Males BXD
|
|
GS36592: Whole Brain Gene expression correlates of Morphine vertical activity counts minutes 90-105 in Females BXD
|
|
GS178125: GO:0052866 phosphatidylinositol phosphate phosphatase activity
|
|
GS178819: GO:0016791 phosphatase activity
|
|
GS176718: HP:0000078 Abnormality of the genital system
|
|
GS176817: HP:0011446 Abnormality of higher mental function
|
|
GS205002: GO:0048856 anatomical structure development
|
|
GS174494: HP:0002564 Malformation of the heart and great vessels
|
|
GS172032: HP:0000366 Abnormality of the nose
|
|
GS173372: HP:0011297 Abnormality of the digits
|
|
GS172801: HP:0000752 Hyperactivity
|
|
GS207857: GO:0009058 biosynthetic process
|
|
GS165466: MP:0003632 abnormal nervous system morphology
|
|
GS191081: GO:0035085 cilium axoneme
|
|
GS190066: GO:0046854 phosphatidylinositol phosphorylation
|
|
GS201023: GO:0071704 organic substance metabolic process
|
|
GS187461: GO:0019751 polyol metabolic process
|
|
GS170964: HP:0000152 Abnormality of head and neck
|
|
GS129114: collagen induced arthritis QTL 4 (Cia4 Published QTL Chr 2)
|
|
GS175674: HP:0007360 Aplasia/Hypoplasia of the cerebellum
|
|
GS191106: GO:0044464 cell part
|
|
GS177570: GO:0016043 cellular component organization
|
|
GS208893: GO:0005856 cytoskeleton
|
|
GS193026: GO:0005930 axoneme
|
|
GS172416: HP:0002242 Abnormality of the intestine
|